映恩生物-B(HK09606)、药捷安康-B(HK02617)、维立志博-B(HK09887)等创新药公司在港股上市首日相继大涨,不断刷新年内创新药板块纪录。如今,又一家创新药企复制了这一亮眼成绩。8月11日,中慧生物-B(HK02627,股价33.28港元,市值130.94亿港元)成功登陆港交所主板,其发售价为每股12.9港元。上市首日,中慧生物以33.0港元/股的价格开盘,盘中涨幅一度逼近...
Source Link映恩生物-B(HK09606)、药捷安康-B(HK02617)、维立志博-B(HK09887)等创新药公司在港股上市首日相继大涨,不断刷新年内创新药板块纪录。如今,又一家创新药企复制了这一亮眼成绩。8月11日,中慧生物-B(HK02627,股价33.28港元,市值130.94亿港元)成功登陆港交所主板,其发售价为每股12.9港元。上市首日,中慧生物以33.0港元/股的价格开盘,盘中涨幅一度逼近...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.